Related Materials - European Society of Cardiology

ESC/EACTS Page 22 of 34
before radiofrequency ablation in patients presenting with
paroxysmal supraventricular tachycardia. J Cardiovasc Pharmacol
Ther 2007;12(2):137-144.
Lazorishinets VV, Glagola MD, Stychinsky AS, Rudenko MN,
Knyshov GV. Surgical treatment of Wolf-Parkinson-White
syndrome during plastic operations in patients with Ebstein’s
anomaly. Eur J Cardiothorac Surg 2000;18(4):487-490.
Nucifora G, Schuijf JD, Tops LF, van Werkhoven JM, Kajander S,
Jukema JW, Schreur JH, Heijenbrok MW, Trines SA, Gaemperli
O, Turta O, Kaufmann PA, Knuuti J, Schalij MJ, Bax JJ. Prevalence
of coronary artery disease assessed by multislice computed
tomography coronary angiography in patients with paroxysmal or
persistent atrial fibrillation. Circ Cardiovasc Imaging 2009;2(2):100-
106.
9.7.3 Ventricular arrhythmias
A comparison of antiarrhythmic-drug therapy with implantable
defibrillators in patients resuscitated from near-fatal ventricular
arrhythmias. The Antiarrhythmics versus Implantable Defibrillators
(AVID) Investigators. N Engl J Med 1997;337(22):1576-1583.
Aliot EM, Stevenson WG, Almendral-Garrote JM, Bogun F, Calkins
CH, Delacretaz E, Bella PD, Hindricks G, Jais P, Josephson ME,
Kautzner J, Kay GN, Kuck KH, Lerman BB, Marchlinski F, Reddy
V, Schalij MJ, Schilling R, Soejima K, Wilber D. EHRA/HRS Expert
Consensus on Catheter Ablation of Ventricular Arrhythmias:
developed in a partnership with the European Heart Rhythm
Association (EHRA), a Registered Branch of the European
Society of Cardiology (ESC), and the Heart Rhythm Society
(HRS); in collaboration with the American College of Cardiology
(ACC) and the American Heart Association (AHA). Europace
2009;11(6):771-817.
Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R,
Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE,
Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP,
Luceri RM, Ip JH. Amiodarone or an implantable cardioverterdefibrillator
for congestive heart failure. N Engl J Med
2005;352(3):225-237.
Barletta G, Toso A, Del BR, Di DM, Sabatier M, Dor V. Preoperative
and late postoperative mitral regurgitation in ventricular
reconstruction: role of local left ventricular deformation. Ann
Thorac Surg 2006;82(6):2102-2109.
Bax JJ, Braun J, Somer ST, Klautz R, Holman ER, Versteegh MI,
Boersma E, Schalij MJ, van der Wall EE, Dion RA. Restrictive
annuloplasty and coronary revascularization in ischemic mitral
regurgitation results in reverse left ventricular remodeling.
Circulation 2004;110(11 Suppl 1):II103-II108.
Bax JJ, Wijns W, Cornel JH, Visser FC, Boersma E, Fioretti PM.
Accuracy of currently available techniques for prediction of
functional recovery after revascularization in patients with left
ventricular dysfunction due to chronic coronary artery disease:
comparison of pooled data. J Am Coll Cardiol 1997;30(6):1451-
1460.
Bonow RO. Identification of viable myocardium. Circulation
1996;94(11):2674-2680.
Brugada J, Aguinaga L, Mont L, Betriu A, Mulet J, Sanz G. Coronary
artery revascularization in patients with sustained ventricular
arrhythmias in the chronic phase of a myocardial infarction:
effects on the electrophysiologic substrate and outcome. J Am
Coll Cardiol 2001;37(2):529-533.
Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN,
Hafley G. A randomized study of the prevention of sudden death
in patients with coronary artery disease. Multicenter Unsustained
Tachycardia Trial Investigators. N Engl J Med 1999;341(25):1882-
1890.
Cook JR, Rizo-Patron C, Curtis AB, Gillis AM, Bigger JT, Jr., Kutalek
SP, Coromilas J, Hofer BI, Powell J, Hallstrom AP. Effect of surgical
revascularization in patients with coronary artery disease and
ventricular tachycardia or fibrillation in the Antiarrhythmics
Versus Implantable Defibrillators (AVID) Registry. Am Heart J
2002;143(5):821-826.
de Vreede-Swagemakers JJ, Gorgels AP, Dubois-Arbouw WI, van
Ree JW, Daemen MJ, Houben LG, Wellens HJ. Out-of-hospital
cardiac arrest in the 1990’s: a population-based study in the
Maastricht area on incidence, characteristics and survival. J Am
Coll Cardiol 1997;30(6):1500-1505.
Di Carli MF. Assessment of myocardial viability after myocardial
infarction. J Nucl Cardiol 2002;9(2):229-235.
Elhendy A, Bax JJ, Poldermans D. Dobutamine stress myocardial
perfusion imaging in coronary artery disease. J Nucl Med
2002;43(12):1634-1646.
Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA, III, Freedman
RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes
DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ,
Stevenson LW, Sweeney MO, Smith SC, Jr., Jacobs AK, Adams
CD, Anderson JL, Buller CE, Creager MA, Ettinger SM, Faxon DP,
Halperin JL, Hiratzka LF, Hunt SA, Krumholz HM, Kushner FG,
Lytle BW, Nishimura RA, Ornato JP, Page RL, Riegel B, Tarkington
LG, Yancy CW. ACC/AHA/HRS 2008 Guidelines for Device-
Based Therapy of Cardiac Rhythm Abnormalities: a report of the
American College of Cardiology/American Heart Association
Task Force on Practice Guidelines (Writing Committee to Revise
the ACC/AHA/NASPE 2002 Guideline Update for Implantation
of Cardiac Pacemakers and Antiarrhythmia Devices) developed
in collaboration with the American Association for Thoracic
Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol
2008;51(21):e1-62.
Every NR, Fahrenbruch CE, Hallstrom AP, Weaver WD, Cobb LA.
Influence of coronary bypass surgery on subsequent outcome of
patients resuscitated from out of hospital cardiac arrest. J Am
Coll Cardiol 1992;19(7):1435-1439.
Geelen P, Primo J, Wellens F, Brugada P. Coronary artery bypass
grafting and defibrillator implantation in patients with ventricular
tachyarrhythmias and ischemic heart disease. Pacing Clin
Electrophysiol 1999;22(8):1132-1139.
Goldberger JJ, Cain ME, Hohnloser SH, Kadish AH, Knight BP,
Lauer MS, Maron BJ, Page RL, Passman RS, Siscovick D, Stevenson
WG, Zipes DP. American Heart Association/American College
of Cardiology Foundation/Heart Rhythm Society Scientific
Statement on Noninvasive Risk Stratification Techniques for
Identifying Patients at Risk for Sudden Cardiac Death. A scientific
statement from the American Heart Association Council on
Clinical Cardiology Committee on Electrocardiography and
Arrhythmias and Council on Epidemiology and Prevention. J Am
Coll Cardiol 2008;52(14):1179-1199.
Goldenberg I, Vyas AK, Hall WJ, Moss AJ, Wang H, He H, Zareba W,
McNitt S, Andrews ML. Risk stratification for primary implantation
of a cardioverter-defibrillator in patients with ischemic left
ventricular dysfunction. J Am Coll Cardiol 2008;51(3):288-296.
Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson
KP, Calkins H, Hoch D, Goldberger J, Shalaby A, Sanders WE,
Schaechter A, Levine JH. Prophylactic defibrillator implantation in
patients with nonischemic dilated cardiomyopathy. N Engl J Med
2004;350(21):2151-2158.
Kelly P, Ruskin JN, Vlahakes GJ, Buckley MJ, Jr., Freeman CS, Garan
H. Surgical coronary revascularization in survivors of prehospital
cardiac arrest: its effect on inducible ventricular arrhythmias and
long-term survival. J Am Coll Cardiol 1990;15(2):267-273.
Lee KS, Marwick TH, Cook SA, Go RT, Fix JS, James KB, Sapp
SK, MacIntyre WJ, Thomas JD. Prognosis of patients with left
ventricular dysfunction, with and without viable myocardium